Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.

Chapiro E, Pramil E, Diop M, Roos-Weil D, Dillard C, Gabillaud C, Maloum K, Settegrana C, Baseggio L, Lesesve JF, Yon M, Jondreville L, Lesty C, Davi FB, Le Garff-Tavernier M, Droin NM, Dessen P, Algrin C, Leblond V, Gabarre J, Bouzy S, Eclache V, Gaillard B, Callet-Bauchu E, Muller M, Lefebvre C, Nadal N, Ittel A, Struski S, Collonge-Rame MA, Quilichini B, Fert-Ferrer S, Auger N, Radford-Weiss I, Wagner L, Scheinost S, Zenz T, Susin SA, Bernard OA, Nguyen-Khac F.

Blood. 2019 Sep 16. pii: blood.2019001187. doi: 10.1182/blood.2019001187. [Epub ahead of print]

PMID:
31527074
2.

Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features.

Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytogénétique Hématologique.

Am J Hematol. 2019 Nov;94(11):E285-E288. doi: 10.1002/ajh.25601. Epub 2019 Aug 26. No abstract available.

PMID:
31379011
3.

Circulation of spotted fever group rickettsiae among dogs seropositive for Leishmania spp. in an urban area of Brazil.

Campos SDE, Nadal NV, Toma HK, Almeida AB, Cordeiro MD, Fonseca AHD, Figueiredo FB, Verícimo MA, Cunha NCD, Almosny NRP.

Rev Soc Bras Med Trop. 2019 Feb 21;52:e20180133. doi: 10.1590/0037-8682-0133-2018.

4.

Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.

Bidet A, Dulucq S, Smol T, Marceau-Renaut A, Morisset S, Coiteux V, Noël-Walter MP, Nicolini FE, Tigaud I, Luquet I, Struski S, Gaillard B, Penther D, Tondeur S, Nadal N, Hermet E, Véronèse L, Réa D, Gervais C, Theisen O, Terré C, Cony-Makhoul P, Lefebvre C, Gaillard JB, Radford I, Vervaeke AL, Barin C, Chapiro E, Nguyen-Khac F, Etienne G, Preudhomme C, Mahon FX, Roche-Lestienne C; Groupe Francophone de Cytogénétique Hématologique (GFCH) and the French Intergroup of Chronic Myeloid Leukemia (Fi-LMC).

Haematologica. 2019 Jun;104(6):1150-1155. doi: 10.3324/haematol.2018.208801. Epub 2018 Dec 20.

5.

Management of obstructive sleep apnoea in a primary care vs sleep unit setting: a randomised controlled trial.

Tarraubella N, Sánchez-de-la-Torre M, Nadal N, De Batlle J, Benítez I, Cortijo A, Urgelés MC, Sanchez V, Lorente I, Lavega MM, Fuentes A, Clotet J, Llort L, Vilo L, Juni MC, Juarez A, Gracia M, Castro-Grattoni AL, Pascual L, Minguez O, Masa JF, Barbé F.

Thorax. 2018 Dec;73(12):1152-1160. doi: 10.1136/thoraxjnl-2017-211237. Epub 2018 Jul 31.

PMID:
30064993
6.

Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies.

Magne J, Jenvrin A, Chauchet A, Casasnovas O, Donzel A, Jego L, Aral B, Guy J, Nadal N, Vernerey D, Callier P, Garnache-Ottou F, Ferrand C.

Exp Hematol Oncol. 2018 Feb 20;7:5. doi: 10.1186/s40164-018-0097-6. eCollection 2018.

7.

"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.

Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, Le Garff-Tavernier M, Bougacha N, Struski S, Bidet A, Laharanne E, Barin C, Veronese L, Prié N, Eclache V, Gaillard B, Michaux L, Lefebvre C, Gaillard JB, Terré C, Penther D, Bastard C, Nadal N, Fert-Ferrer S, Auger N, Godon C, Sutton L, Tournilhac O, Susin SA, Nguyen-Khac F; GroupeFrancophone de Cytogénétique Hématologique(GFCH) and the French Innovative Leukemia Organization (FILO) group.

Am J Hematol. 2018 Mar;93(3):375-382. doi: 10.1002/ajh.24990. Epub 2017 Dec 18.

8.

Predictors of CPAP compliance in different clinical settings: primary care versus sleep unit.

Nadal N, de Batlle J, Barbé F, Marsal JR, Sánchez-de-la-Torre A, Tarraubella N, Lavega M, Sánchez-de-la-Torre M.

Sleep Breath. 2018 Mar;22(1):157-163. doi: 10.1007/s11325-017-1549-7. Epub 2017 Sep 1.

PMID:
28865067
9.

Early thymic precursor-like lymphomatous presentation of the ETV6-NCOA2 translocation.

Bond J, Touzart A, Nadal N, Trinquand A, Thouvenin S, Da Cruz V, Bonté PE, Radford-Weiss I, Garnier N, Stéphan JL, Macintyre E.

Br J Haematol. 2018 May;181(3):392-394. doi: 10.1111/bjh.14579. Epub 2017 Mar 8. No abstract available.

PMID:
28272805
10.

GESAP trial rationale and methodology: management of patients with suspected obstructive sleep apnea in primary care units compared to sleep units.

Tarraubella N, de Batlle J, Nadal N, Castro-Grattoni AL, Gómez S, Sánchez-de-la-Torre M, Barbé F.

NPJ Prim Care Respir Med. 2017 Feb 7;27(1):8. doi: 10.1038/s41533-016-0010-x. No abstract available.

11.

Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).

Lefebvre C, Callet-Bauchu E, Chapiro E, Nadal N, Penther D, Poirel HA.

Ann Biol Clin (Paris). 2016 Oct 1;74(5):568-587. Review.

12.

NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.

Struski S, Lagarde S, Bories P, Puiseux C, Prade N, Cuccuini W, Pages MP, Bidet A, Gervais C, Lafage-Pochitaloff M, Roche-Lestienne C, Barin C, Penther D, Nadal N, Radford-Weiss I, Collonge-Rame MA, Gaillard B, Mugneret F, Lefebvre C, Bart-Delabesse E, Petit A, Leverger G, Broccardo C, Luquet I, Pasquet M, Delabesse E.

Leukemia. 2017 Mar;31(3):565-572. doi: 10.1038/leu.2016.267. Epub 2016 Oct 3.

PMID:
27694926
13.

Knowledge management through two virtual communities of practice (Endobloc and Pneumobloc).

Lara B, Cañas F, Vidal A, Nadal N, Rius F, Paredes E, Hernández M, Maravall FJ, Franch-Nadal J, Barbé F, Mauricio D.

Health Informatics J. 2017 Sep;23(3):170-180. doi: 10.1177/1460458216639739. Epub 2016 Apr 21.

PMID:
27102887
14.

Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial.

Sánchez-de-la-Torre M, Nadal N, Cortijo A, Masa JF, Duran-Cantolla J, Valls J, Serra S, Sánchez-de-la-Torre A, Gracia M, Ferrer F, Lorente I, Urgeles MC, Alonso T, Fuentes A, Armengol F, Lumbierres M, Vázquez-Polo FJ, Barbé F; Respiratory Medicine Research Group.

Thorax. 2015 Apr;70(4):346-52. doi: 10.1136/thoraxjnl-2014-206287.

PMID:
25766689
15.

14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.

Cosson A, Chapiro E, Belhouachi N, Cung HA, Keren B, Damm F, Algrin C, Lefebvre C, Fert-Ferrer S, Luquet I, Gachard N, Mugneret F, Terre C, Collonge-Rame MA, Michaux L, Rafdord-Weiss I, Talmant P, Veronese L, Nadal N, Struski S, Barin C, Helias C, Lafage M, Lippert E, Auger N, Eclache V, Roos-Weil D, Leblond V, Settegrana C, Maloum K, Davi F, Merle-Beral H, Lesty C, Nguyen-Khac F; Groupe Francophone de Cytogénétique Hématologique.

Genes Chromosomes Cancer. 2014 Aug;53(8):657-66. doi: 10.1002/gcc.22176. Epub 2014 Apr 12.

PMID:
24729385
16.

Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature.

Chapiro E, Radford-Weiss I, Cung HA, Dastugue N, Nadal N, Taviaux S, Barin C, Struski S, Talmant P, Vandenberghe P, Mozziconacci MJ, Tigaud I, Lefebvre C, Penther D, Bastard C, Lippert E, Mugneret F, Romana S, Bernard OA, Harrison CJ, Russell LJ, Nguyen-Khac F; Groupe Francophone de Cytogénétique Hématologique.

Cancer Genet. 2013 May;206(5):162-73. doi: 10.1016/j.cancergen.2013.04.004. Epub 2013 Jul 1. Review.

PMID:
23827691
17.

Heat Shock Protein 90 is overexpressed in high-risk myelodysplastic syndromes and associated with higher expression and activation of Focal Adhesion Kinase.

Flandrin-Gresta P, Solly F, Aanei CM, Cornillon J, Tavernier E, Nadal N, Morteux F, Guyotat D, Wattel E, Campos L.

Oncotarget. 2012 Oct;3(10):1158-68.

18.

Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.

Havelange V, Ameye G, Théate I, Callet-Bauchu E, Mugneret F, Michaux L, Dastugue N, Penther D, Barin C, Collonge-Rame MA, Baranger L, Terré C, Nadal N, Lippert E, Laï JL, Cabrol C, Tigaud I, Herens C, Hagemeijer A, Raphael M, Libouton JM, Poirel HA; GFCH (Groupe Francophone de Cytogénétique Hématologique).

Genes Chromosomes Cancer. 2013 Jan;52(1):81-92. doi: 10.1002/gcc.22008. Epub 2012 Sep 25.

PMID:
23012230
19.

LHX2 deregulation by juxtaposition with the IGH locus in a pediatric case of chronic myeloid leukemia in B-cell lymphoid blast crisis.

Nadal N, Chapiro E, Flandrin-Gresta P, Thouvenin S, Vasselon C, Beldjord K, Fenneteau O, Bernard O, Campos L, Nguyen-Khac F.

Leuk Res. 2012 Sep;36(9):e195-8. doi: 10.1016/j.leukres.2012.05.013. Epub 2012 Jun 22. No abstract available.

PMID:
22727509
20.

PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.

Duhoux FP, Ameye G, Montano-Almendras CP, Bahloula K, Mozziconacci MJ, Laibe S, Wlodarska I, Michaux L, Talmant P, Richebourg S, Lippert E, Speleman F, Herens C, Struski S, Raynaud S, Auger N, Nadal N, Rack K, Mugneret F, Tigaud I, Lafage M, Taviaux S, Roche-Lestienne C, Latinne D, Libouton JM, Demoulin JB, Poirel HA; Groupe Francophone de Cytogénétique Hématologique (GFCH); Belgian Cytogenetic Group for Haematology and Oncology (BCG-HO).

Br J Haematol. 2012 Jan;156(1):76-88. doi: 10.1111/j.1365-2141.2011.08918.x. Epub 2011 Nov 3.

PMID:
22050763
21.

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Duhoux FP, Ameye G, Lambot V, Herens C, Lambert F, Raynaud S, Wlodarska I, Michaux L, Roche-Lestienne C, Labis E, Taviaux S, Chapiro E, Nguyen-Khac F, Struski S, Dobbelstein S, Dastugue N, Lippert E, Speleman F, Van Roy N, De Weer A, Rack K, Talmant P, Richebourg S, Mugneret F, Tigaud I, Mozziconacci MJ, Laibe S, Nadal N, Terré C, Libouton JM, Decottignies A, Vikkula M, Poirel HA; Groupe Francophone de Cytogénétique Hématologique (GFCH); Belgian Cytogenetic Group for Hematology and Oncology (BCG-HO).

PLoS One. 2011;6(10):e26311. doi: 10.1371/journal.pone.0026311. Epub 2011 Oct 21. Erratum in: PLoS One. 2011 Dec 13;6(12). doi: 10.1371/annotation/3b5aaa87-72b6-49d3-9ec9-f4a656e12e3a. Khac, Florence Nguyen [corrected to Nguyen-Khac, Florence].

22.

Congenital acute leukemia with initial indolent presentation--a case report.

Campos L, Nadal N, Flandrin-Gresta P, Vasselon C, Aanei C, Berger C, Stephan JL.

Cytometry B Clin Cytom. 2011 Mar;80(2):130-3. doi: 10.1002/cyto.b.20578. Epub 2010 Dec 2.

23.

Transmission of leukemic donor cells by allogeneic stem cell transplantation in a context of familial CLL: should we screen donors for MBL?

Flandrin-Gresta P, Callanan M, Nadal N, Jaubert J, Cornillon J, Guyotat D, Campos L.

Blood. 2010 Dec 2;116(23):5077-8. doi: 10.1182/blood-2010-08-300673. No abstract available.

PMID:
21127190
24.

Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations.

Nguyen-Khac F, Lesty C, Eclache V, Couronné L, Kosmider O, Andrieux J, Collonge-Rame MA, Penther D, Lafage M, Bilhou-Nabera C, Chapiro E, Mozziconacci MJ, Mugneret F, Gachard N, Nadal N, Lippert E, Struski S, Dastugue N, Cabrol C, Bernard OA; Groupe Francophone de Cytogénétique Hématologique.

Genes Chromosomes Cancer. 2010 Oct;49(10):919-27. doi: 10.1002/gcc.20802.

PMID:
20629097
25.

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.

Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, Bousquet M, Mugneret F, Talmant P, Pages MP, Lefebvre C, Penther D, Lippert E, Nadal N, Taviaux S, Poppe B, Luquet I, Baranger L, Eclache V, Radford I, Barin C, Mozziconacci MJ, Lafage-Pochitaloff M, Antoine-Poirel H, Charrin C, Perot C, Terre C, Brousset P, Dastugue N, Broccardo C.

Blood. 2010 Apr 15;115(15):3089-97. doi: 10.1182/blood-2009-07-234229. Epub 2010 Feb 16.

PMID:
20160164
26.

Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.

Couronné L, Lippert E, Andrieux J, Kosmider O, Radford-Weiss I, Penther D, Dastugue N, Mugneret F, Lafage M, Gachard N, Nadal N, Bernard OA, Nguyen-Khac F.

Leukemia. 2010 Jan;24(1):201-3. doi: 10.1038/leu.2009.169. Epub 2009 Aug 27. No abstract available.

PMID:
19710701
27.

Clinical and biochemical spectrum of mitochondrial complex III deficiency caused by mutations in the BCS1L gene.

Ramos-Arroyo MA, Hualde J, Ayechu A, De Meirleir L, Seneca S, Nadal N, Briones P.

Clin Genet. 2009 Jun;75(6):585-7. doi: 10.1111/j.1399-0004.2009.01160.x. No abstract available.

PMID:
19508421
28.

Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.

Tavernier-Tardy E, Cornillon J, Campos L, Flandrin P, Duval A, Nadal N, Guyotat D.

Leuk Res. 2009 Jun;33(6):764-8. doi: 10.1016/j.leukres.2008.10.014. Epub 2008 Nov 29.

PMID:
19042019
29.

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.

Graux C, Stevens-Kroef M, Lafage M, Dastugue N, Harrison CJ, Mugneret F, Bahloula K, Struski S, Grégoire MJ, Nadal N, Lippert E, Taviaux S, Simons A, Kuiper RP, Moorman AV, Barber K, Bosly A, Michaux L, Vandenberghe P, Lahortiga I, De Keersmaecker K, Wlodarska I, Cools J, Hagemeijer A, Poirel HA; Groupe Francophone de Cytogénétique Hématologique; Belgian Cytogenetic Group for Hematology and Oncology.

Leukemia. 2009 Jan;23(1):125-33. doi: 10.1038/leu.2008.278. Epub 2008 Oct 16.

PMID:
18923437
30.

Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases.

Murati A, Gervais C, Carbuccia N, Finetti P, Cervera N, Adélaïde J, Struski S, Lippert E, Mugneret F, Tigaud I, Penther D, Bastard C, Poppe B, Speleman F, Baranger L, Luquet I, Cornillet-Lefebvre P, Nadal N, Nguyen-Khac F, Pérot C, Olschwang S, Bertucci F, Chaffanet M, Lessard M, Mozziconacci MJ, Birnbaum D; Groupe Francophone de Cytogénétique Hématologique.

Leukemia. 2009 Jan;23(1):85-94. doi: 10.1038/leu.2008.257. Epub 2008 Sep 25.

PMID:
18818702
31.

Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.

Gervais C, Murati A, Helias C, Struski S, Eischen A, Lippert E, Tigaud I, Penther D, Bastard C, Mugneret F, Poppe B, Speleman F, Talmant P, VanDen Akker J, Baranger L, Barin C, Luquet I, Nadal N, Nguyen-Khac F, Maarek O, Herens C, Sainty D, Flandrin G, Birnbaum D, Mozziconacci MJ, Lessard M; Groupe Francophone de Cytogénétique Hématologique.

Leukemia. 2008 Aug;22(8):1567-75. doi: 10.1038/leu.2008.128. Epub 2008 Jun 5.

PMID:
18528428
32.

Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells.

Flandrin P, Guyotat D, Duval A, Cornillon J, Tavernier E, Nadal N, Campos L.

Cell Stress Chaperones. 2008 Sep;13(3):357-64. doi: 10.1007/s12192-008-0035-3. Epub 2008 Apr 3.

33.

RUNX1 rearrangements in acute myeloblastic leukemia relapsing after hematopoietic stem cell transplantation.

Nadal N, Stephan JL, Cornillon J, Guyotat D, Flandrin P, Campos L.

Cancer Genet Cytogenet. 2008 Jan 15;180(2):168-9. doi: 10.1016/j.cancergencyto.2007.10.020. No abstract available.

PMID:
18206548
34.

Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.

Olaru D, Campos L, Flandrin P, Nadal N, Duval A, Chautard S, Guyotat D.

Cytometry B Clin Cytom. 2008 Jan;74(1):17-24.

35.

Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH).

Luquet I, Laï JL, Barin C, Baranger L, Bilhou-Nabera C, Lippert E, Gervais C, Talmant P, Cornillet-Lefebvre P, Perot C, Nadal N, Mozziconacci MJ, Lafage-Pochitaloff M, Eclache V, Mugneret F, Lefebvre C, Herens C, Speleman F, Poirel H, Tigaud I, Cabrol C, Rousselot P, Daliphard S, Imbert M, Garand R, Geneviève F, Berger R, Terre C; Francophone de Cytogenetique Hematologique.

Leukemia. 2008 Jan;22(1):132-7. Epub 2007 Oct 11.

PMID:
17928884
36.

Successful treatment with imatinib mesylate in a case of chronic myeloproliferative disorder with a t(5;12)(q33;p13.1) without eosinophilia.

Nadal N, Flandrin P, Cornillon J, Delabesse E, Mauvieux L, Olaru D, Morel S, Campos L.

Cancer Genet Cytogenet. 2006 Sep;169(2):174-5. No abstract available.

PMID:
16938578
37.

Expression and prognostic significance of heat-shock proteins in myelodysplastic syndromes.

Duval A, Olaru D, Campos L, Flandrin P, Nadal N, Guyotat D.

Haematologica. 2006 May;91(5):713-4.

38.

NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.

Romana SP, Radford-Weiss I, Ben Abdelali R, Schluth C, Petit A, Dastugue N, Talmant P, Bilhou-Nabera C, Mugneret F, Lafage-Pochitaloff M, Mozziconacci MJ, Andrieu J, Lai JL, Terre C, Rack K, Cornillet-Lefebvre P, Luquet I, Nadal N, Nguyen-Khac F, Perot C, Van den Akker J, Fert-Ferrer S, Cabrol C, Charrin C, Tigaud I, Poirel H, Vekemans M, Bernard OA, Berger R; Groupe Francophone de Cytogénétique Hématologique.

Leukemia. 2006 Apr;20(4):696-706.

PMID:
16467868
39.

A method for risk assessment for three contaminated sites in northern Italy.

Critto A, Nadal N, Carlon C, Marcomini A.

Ann Chim. 2005 Nov-Dec;95(11-12):833-44.

PMID:
16398347
40.

Spinocerebellar ataxia type 2 (SCA2) with white matter involvement.

Armstrong J, Bonaventura I, Rojo A, González G, Corral J, Nadal N, Volpini V, Ferrer I.

Neurosci Lett. 2005 Jun 24;381(3):247-51. Epub 2005 Mar 17.

PMID:
15896478
41.

French multi-centric study of 2000 amniotic fluid interphase FISH analyses from high-risk pregnancies and review of the literature.

Luquet I, Mugneret F, Athis PD, Nadal N, Favre B, Abel C, Chelloug N, Lespinasse J, Portnoi MF, Joyé N, Dupont JM, Lebbar A, Bresson JL, Fellmann F, Siffroi JP, Chantot-Bastaraud S, Chiesa J, Amblard F, Devillard F, Jeandidier E, Boceno M, Rival JM, Bellec V, Lallaoui H, Delobel B, Croquette MF, Benzacken B.

Ann Genet. 2002 Apr-Jun;45(2):77-88. Review.

PMID:
12119216
42.

Prenatal diagnosis of a partial trisomy 7q in two fetuses with bilateral ventriculomegaly.

Robinet C, Douvier S, Khau Van Kien P, Favre B, Luquet I, Nadal N, Nivelon-Chevallier A, Mugneret F.

Prenat Diagn. 2000 Nov;20(11):936-8. No abstract available.

PMID:
11113903
43.

Homozygosity mapping of giant axonal neuropathy gene to chromosome 16q24.1.

Ben Hamida C, Cavalier L, Belal S, Sanhaji H, Nadal N, Barhoumi C, M'Rissa N, Marzouki N, Mandel JL, Ben Hamida M, Koenig M, Hentati F.

Neurogenetics. 1997 Sep;1(2):129-33.

PMID:
10732815
44.

del(6)(q12q15) as the sole cytogenetic anomaly in a case of solitary infantile myofibromatosis.

Stenman G, Nadal N, Persson S, Gunterberg B, Angervall L.

Oncol Rep. 1999 Sep-Oct;6(5):1101-4.

PMID:
10425309
45.

Two cases of terminal deletion of chromosome 13: clinical features, conventional and molecular cytogenetic analysis.

Luquet I, Favre B, Nadal N, Madinier N, Khau Van Kien P, Huet F, Nivelon-Chevallier A, Mugneret F.

Ann Genet. 1999;42(1):33-9.

PMID:
10214505
46.

Localization of Refsum disease with increased pipecolic acidaemia to chromosome 10p by homozygosity mapping and carrier testing in a single nuclear family.

Nadal N, Rolland MO, Tranchant C, Reutenauer L, Gyapay G, Warter JM, Mandel JL, Koenig M.

Hum Mol Genet. 1995 Oct;4(10):1963-6.

PMID:
8595422
47.

Trisomy 13 in a case of acute promyelocytic leukemia.

Valtat C, Uettwiller F, Nadal N, Oberling F.

Cancer Genet Cytogenet. 1992 Sep;62(2):206-7. No abstract available.

PMID:
1394112

Supplemental Content

Support Center